| SGLT2i | Sodium-glucose cotransporter 2 inhibitor |
| PD | Peritoneal dialysis |
| HD | Hemodialysis |
| KF | Kidney failure |
| KRT | Kidney replacement therapy |
| HF | Heart failure |
| CKD | Chronic kidney disease |
| T2DM | Type 2 diabetes mellitus |
| EHR | Electronic health records |
| PSM | Propensity score matching |
| MACE | Major adverse cardiovascular events |
| SNOMED | Systematized Nomenclature of Medicine |
| ICD-10 | International Classification of Diseases, 10th Revision |
| HCO | Health care organization |
| IQR | Interquartile range |
| SD | Standard deviation |
| CI | Confidence interval |
| HR | Hazard ratio |
| CIHD | Chronic ischemic heart disease |
| CLRD | Chronic lower respiratory disease |
| BMI | Body mass index |
| GFR | Glomerular filtration rate |
| SBP | Systolic blood pressure |
| DBP | Diastolic blood pressure |
| BNP | B-type natriuretic peptide |
| TG | Triglycerides |
| HDL | High-density lipoprotein |
| LDL | Low-density lipoprotein |
| AST | Aspartate aminotransferase |
| ALT | Alanine aminotransferase |
| RASi | Renin–angiotensin system inhibition |
| HbA1c | Hemoglobin A1c |
| STROBE | Strengthening the Reporting of Observational Studies in Epidemiology |